Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. WallCann - Cura-Care.com
WARNING LETTER
•WallCann - Cura-Care.com

WallCann - Cura-Care.com – FDA Warning Letter

Record Details

The FDA reviewed WallCann - Cura-Care.com's website, www.cura-care.com, and determined that Curaderm-BEC5 is promoted and sold to mitigate, prevent, treat, or cure disease in humans, or to affect the structure or function of the body. Statements on the website claim Curaderm-BEC5 is a "clinically proven, cost effective treatment for both primary and secondary skin cancer care," can treat various skin cancers and sunspots, and allows users to "avoid painful Surgery, Radiotherapy, Chemotherapy or other conventional treatments."

The FDA classified Curaderm-BEC5 as a drug under section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (the Act) due to its intended uses. Furthermore, it is deemed a new drug under section 201(p) of the Act because it is not generally recognized as safe and effective for its advertised uses. The sale of this product without an FDA-approved application violates sections 301(d) and 505(a) of the Act.

Additionally, the product is considered misbranded under section 502(f)(1) of the Act because it is offered for conditions (e.g., cancer) not amenable to self-diagnosis and treatment by laypersons, meaning adequate directions for safe use cannot be provided.

WallCann is advised to review all websites, product labels,

Company
WallCann - Cura-Care.com
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Michael M. Levy
  • Mark Doverty (Dr.)
View Company Profile

ID · 7a49434b-bbff-472c-9f97-3845cc0e8b17

Violation Codes5
21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore WallCann - Cura-Care.com
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.